Furthermore, analysis of an array of invasion-associated genes after AHR knockdown suggested plausible mechanisms through which the AHR drives tumor invasion, further supporting the conclusion that AHR inhibition, at least in these TNBC and IBC lines, reduces tumor aggression. Here, AHR is linked to inflammatory breast carcinoma.